Please Subscribe to get a daily link to Pat's blog via email


Your privacy is important to us. We will never spam you and keep your personal data secure.

financial news

Home/Tag:financial news
8 06, 2014

Health Canada’s approval of Pomalyst only first step

Tags: , , , |4 Comments

Interested in how myeloma drugs are approved and paid for in other countries?  It can get complicated.  Here's a notification from Myeloma Canada, notifying patients and caregivers that despite a recommendation for public funding,  individual provinces have not approved Pomalyst (pomalidomide) yet: Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 /* Style Definitions */

25 08, 2013

BREAKING NEWS: Amgen to buy Onyx Pharmaceuticals

Tags: , , , , |13 Comments

This is BIG NEWS, especially for a Sunday afternoon: Amgen to Acquire Onyx Pharmaceuticals for $125 per Share in Cash Attractive Addition to Amgen's Leading Oncology Portfolio and Pipeline Kyprolis(R) (carfilzomib) for Injection Is at Early Stages of Launch in Multiple Myeloma; Showing Strong Physician Support Acquisition Expected to Contribute to Growth and Value for

20 04, 2013

Big pharma isn’t all bad; 23 companies working hard to help relapsed myeloma patients

Tags: , |11 Comments

WOW!  Check-out how many companies are actively involved in developing chemotherapy for relapsed multiple myeloma patients as listed in a press release run in the Wall Street Journal April 18th: Companies Involved in Refractory Multiple Myeloma Therapeutics Development -- Bristol-Myers Squibb Company -- Johnson & Johnson -- Eli Lilly and Company -- GlaxoSmithKline plc --